Bionomics Limited/Fi

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Bionomics Limited/Fi
TickerNEUP
CIK #0001191070
CUSIP64136E102
SectorLife Sciences - Pharmaceutical Preparations
Address200 Greenhill Road, Eastwood Sa, 5063
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Bionomics Limited/Fi 2012-09-27 10.4 M Exemption: 506 · Minimum: $1 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001191070] 10-K
[0001191070] 10-Q
[0001191070] 3
[0001191070] 4
[0001191070] 6-K
[0001191070] 8-K
[0001191070] D
[0001191070] SC 13D
[0001191070] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Coastlands Capital LP Neuphoria Therapeutics Inc [2025-11-05] 0.0
Shay Capital LLC Neuphoria Therapeutics Inc [2025-10-31] 0.0
Baselake Partners LP Neuphoria Therapeutics Inc [2025-10-31] 0.0
Lynx1 Capital Management LP Neuphoria Therapeutics Inc [2025-10-23] 0.0
Armistice Capital LLC Bionomics Limited/Fi [2024-11-14] 0.99
Lynx1 Capital Management LP Bionomics Limited/Fi [2023-10-30] 8.2
Tang Capital Partners LP Bionomics Limited/Fi [2023-10-10] 8.6
Point72 Asset Management LP Bionomics Limited/Fi [2023-09-29] 8.1
Biotechnology Value Fund L P Bionomics Limited/Fi [2022-02-14] 5.9
Apeiron Investment Group Ltd Bionomics Limited/Fi [2021-12-30] 27.7
Form 3/4/5 Filer 2011 - 2026
Davies Peter Miles Winston
Bionomics Limited/Fi
Ryan Jane
Wilson David Ian
Fisher Alan
Nichols Weston
Lynx1 Capital Management LP
Papapetropoulos Spyros
Cunningham Timothy M
Weaver Aaron Ngoc Dung
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Wilson David Ian
Restricted Stock Units · derivative
2026-01-20 Grant 8,537 $0.00
Fisher Alan
Restricted Stock Units · derivative
2026-01-20 Grant 17,073 $0.00
Davies Peter Miles Winston
Restricted Stock Units · derivative
2026-01-20 Grant 8,537 $0.00
Ryan Jane
Restricted Stock Units · derivative
2026-01-20 Grant 8,537 $0.00
Nichols Weston +1
Common stock, $0.00001 par value per share
2025-10-21 Buy 639,110 $5.14 3,285,025
Employee Stock Option (Right-to- Buy) · derivative
2025-08-27 Grant 34,559 $8.27 285,803
Employee Stock Option (Right-to-Buy) · derivative
2025-04-16 Grant 27,000 $5.16 139,320
Papapetropoulos Spyros
Employee Stock Option (Right-to-Buy) · derivative
2025-04-16 Grant 270,000 $5.16 1,393,200
Davies Peter Miles Winston
Restricted Stock Units · derivative
2025-04-16 Grant 6,783 $0.00
Ryan Jane
Restricted Stock Units · derivative
2025-04-16 Grant 6,783 $0.00
Wilson David Ian
Restricted Stock Units · derivative
2025-04-16 Grant 6,783 $0.00
Fisher Alan
Restricted Stock Units · derivative
2025-04-16 Grant 13,566 $0.00
13F Ownership Over TimeHoldersShares Held
2026-03-31 19 1,731,386
2025-12-31 21 1,439,525
2025-09-30 15 195,338
2025-06-30 10 177,963
2025-03-31 8 163,114
2024-12-31 9 79,720
Form 13F Holdings
Firm Period DFND Voting Shares
FNY Investment Advisers LLC [2026-06-30] SOLE 26,500 26,500
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com